Protective Effects of Sauropus Androgynus Leaf Extract against Isoproterenol Induced Cardiotoxicity

被引:0
|
作者
Preethi S.
Hitesh Kumar
Ramesh C.
Sowmya B. A.
Niveditha K.
Ramkishan Ajmeer
Vikas Jain
机构
[1] JSS College of Pharmacy,Department of Pharmaceutics
[2] JSS Academy of Higher Education and Research,Department of Pharmacology
[3] East West College of Pharmacy,undefined
[4] Central Drugs Standard Control Organisation,undefined
来源
Cardiovascular Toxicology | 2022年 / 22卷
关键词
Cardiotoxicity; Cardio-protective; Isoproterenol; Lactate Dehydrogenase; Creatinine Phosphokinase;
D O I
暂无
中图分类号
学科分类号
摘要
The current research work focuses on the identification of cardioprotective effect of the ethanolic extract of Sauropus androgynus (EESA) leaves. Sauropus androgynus leaves are being utilized in folk and ayurvedic medicines in India to treat cardiovascular diseases like myocardial infraction, atherosclerosis, and venous thrombosis. However, the cardioprotective effects associated with the leaf extract of this plant has not yet been established. Methods: The identification of cardioprotective effects of the ethanolic extract of Sauropus androgynus (EESA) leaves was performed using in vitro and in vivo models. The cell culture studies were performed using cardio myoblast cells (H9C2) and in vivo cardioprotective effects of EESA was assessed in albino wistar rats employing isoproterenol (ISO) as cardiotoxic agent. The animals were divided into six treatment groups and myocardial infraction was induced at 14th day followed by the treatment with therapeutic doses of EESA (100, 200 and 400 mg/kg) for next two days. Various biochemical and histopathological parameters were evaluated in animals kept under control and treatment groups. Results: The in vitro cell line studies revealed a positive impact on H9C2 cells. The ethanolic extract of Sauropus androgynus depicted low toxicity on cardiomyoblast cells and significant proliferation was observed after treatment. The results from animal studies have shown 1.7 times reduction in serum LDH (151.9 ± 1.302) and CPK (237.6 ± 5.781) levels with EESA treated groups compared to toxic control. EESA also significantly increased the antioxidant enzyme levels, which are responsible for cardioprotective effects in animals. Conclusion: This research study reveals that EESA possess antioxidant activity and also provides a protective role against myocardial infarction induced by ISO. We conclude that EESA could be a potential candidate to prevent and treat cardiotoxic consequences of high catecholamine levels.
引用
收藏
页码:579 / 591
页数:12
相关论文
共 50 条
  • [21] Protective effect of Gingko biloba extract against doxorubicin-induced cardiotoxicity in mice
    Naidu, M.U.R.
    Vijay Kumar, K.
    Krishna Mohan, I.
    Sundaram, C.
    Singh, Shashi
    Indian Journal of Experimental Biology, 2002, 40 (08) : 894 - 900
  • [22] PROTECTIVE EFFECTS OF AN AGED GARLIC EXTRACT ON DOXORUBICIN-INDUCED CARDIOTOXICITY IN THE MOUSE
    KOJIMA, R
    TOYAMA, Y
    OHNISHI, ST
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 1994, 22 (02): : 163 - 173
  • [23] Protective effects of Salvia Haenkei extract on a model of Doxorubicin-induced cardiotoxicity
    Lazzarini, Edoardo
    Biemmi, Vanessa
    Balbi, Carolina
    Rendon, Azucena
    Altomare, Claudia
    Giori, Andrea
    Colucci, Manuel
    Alimonti, Andrea
    Barile, Lucio
    VASCULAR PHARMACOLOGY, 2024, 155 : 107327
  • [24] Protective Effects of Pentoxifylline against Adriamycin-induced Cardiotoxicity in Rabbits
    Al-Saedi, Haider F.
    Hussein, Uday Abdul-Reda
    Ramadhan, Mukhallad A.
    JOURNAL OF PHARMACEUTICAL NEGATIVE RESULTS, 2022, 13 (02) : 51 - 56
  • [25] Protective effects of Terminalia arjuna against Doxorubicin-induced cardiotoxicity
    Singh, Gurvinder
    Singh, Anu T.
    Abraham, Aji
    Bhat, Beena
    Mukherjee, Ashok
    Verma, Ritu
    Agarwal, Shiv K.
    Jha, Shivesh
    Mukherjee, Rama
    Burman, Arland C.
    JOURNAL OF ETHNOPHARMACOLOGY, 2008, 117 (01) : 123 - 129
  • [26] Protective effects of chrysoeriol against doxorubicin-induced cardiotoxicity in vitro
    Liu, Z.
    Song, X. D.
    Xin, Y.
    Wang, X. J.
    Yu, H.
    Bai, Y. Y.
    Liu, J. H.
    Zhang, C. N.
    Hui, R. T.
    EUROPEAN HEART JOURNAL, 2009, 30 : 297 - 297
  • [27] Protective effects of magnesium sulfate against doxorubicin induced cardiotoxicity in rats
    Khalilzadeh, Mina
    Abdollahi, Alireza
    Abdolahi, Farhad
    Abdolghaffari, Amir Hossein
    Dehpour, Ahmad Reza
    Jazaeri, Farahnaz
    LIFE SCIENCES, 2018, 207 : 436 - 441
  • [28] In Vivo Protective Effects of Diosgenin against Doxorubicin-Induced Cardiotoxicity
    Chen, Chih-Tai
    Wang, Zhi-Hong
    Hsu, Cheng-Chin
    Lin, Hui-Hsuan
    Chen, Jing-Hsien
    NUTRIENTS, 2015, 7 (06): : 4938 - 4954
  • [29] Protective Effects of Apocynum venetum Against Pirarubicin-Induced Cardiotoxicity
    Zhang, Yang
    Ma, Xiao-Yan
    Zhang, Tong
    Qin, Meng
    Sun, Bo
    Li, Qi
    Hu, Dian-Wen
    Ren, Li-Qun
    AMERICAN JOURNAL OF CHINESE MEDICINE, 2019, 47 (05): : 1075 - 1097
  • [30] Protective effects and mechanisms of psoralidin against adriamycin- induced cardiotoxicity
    Liang, Zhenxing
    Chen, Ying
    Wang, Zheng
    Wu, Xue
    Deng, Chao
    Wang, Changyu
    Yang, Wenwen
    Tian, Ye
    Zhang, Shaofei
    Lu, Chenxi
    Yang, Yang
    JOURNAL OF ADVANCED RESEARCH, 2022, 40 : 249 - 261